BARKER DAVID L 4
4 · Bionano Genomics, Inc. · Filed Jul 11, 2022
Insider Transaction Report
Form 4
BARKER DAVID L
Director
Transactions
- Exercise/Conversion
Common Stock
2022-07-07$0.51/sh+44,470$22,680→ 58,364 total - Exercise/Conversion
Stock Option (Right to Buy)
2022-07-07−44,470→ 0 totalExercise: $0.51Exp: 2030-06-30→ Common Stock (44,470 underlying)
Footnotes (2)
- [F1]The shares vested in equal monthly installments over a one year period such that the option became fully vested on June 30, 2021, subject to full vesting acceleration upon a change in control (as defined in Bionano Genomic's equity incentive plan).
- [F2]The acquisition of the reported option was reported in a Form 4 filed on July 2, 2020, which mistakenly reported the expiration date as 06/30/2029.